| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 20.9K | May 30, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | May 30, 2025 | 1 | $0 | 4 | Jun 3, 2025 | Director |
| ARYD | ARYA Sciences Acquisition Corp IV | Jul 31, 2024 | 0 | $0 | 4 | Jul 31, 2024 | Director |
| PCSC | Perceptive Capital Solutions Corp | Jun 11, 2024 | 0 | $0 | 3 | Jun 11, 2024 | Director |
| ATHA | Athira Pharma, Inc. | May 24, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| ATHA | Athira Pharma, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| ATHA | Athira Pharma, Inc. | May 20, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| ARYE | ARYA Sciences Acquisition Corp V | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Director |
| ATHA | Athira Pharma, Inc. | May 28, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |